# BioFilm

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/biofilm

- Industry: Materials
- Headquarters: Glasgow, UK
- Website: www.biofilm.co.uk
- Total disclosed funding: $4.9M
- Latest round: Series B (May 15, 2013)
- Investors on record: 3

## About

BioFilm Limited is a UK-based firm specializing in the development of innovative dissolving films for dental and wellness applications, enhancing convenience in oral care and health solutions.Founded in 2003 and headquartered in Glasgow, UK, BioFilm Limited focuses on the creation of dissolving film products. The company has executed a total of 4 deals, with the most recent deal occurring on April 11, 2014, when it raised GBP 600,000 in a Series B round, bringing the total amount raised to GBP 600,000 and leading to a current valuation of GBP 5.712 million. The CEO of the company is Ian Stevens.BioFilm Limited, through its Bsolve Dental brand, specializes in the creation of thin dissolving films that cater to oral care and wellness needs. Their product line includes teeth whitening strips that ensure a convenient application process, dissolvable caffeine strips for a quick energy boost, and melatonin strips that facilitate natural sleep. The company serves various sectors including dental, healthcare, and pharmaceuticals, and collaborates with major brands across Europe while also expanding into markets in North America and Asia.In the most recent fiscal year of 2018, BioFilm Limited achieved a revenue of GBP 5,301,890.90. Their revenue strategy primarily involves B2B transactions with partnerships featuring wholesale agreements, where clients purchase products in bulk for resale, thereby enhancing customer satisfaction and loyalty.Moving forward, BioFilm Limited aims to launch additional innovative products in the dissolving film category as part of its growth strategy. The company is also targeting expansion into new geographic markets, particularly in North America and Asia, by 2025. The recent funding secured in April 2014, valuing the company at GBP 5.71 million, will be allocated towards product development and market penetration efforts.

## Funding rounds

- Series B, May 15, 2013, $0.7M — Catapult Ventures Group, Tate & Lyle Ventures, Scottish Enterprise
- Series B, Oct 25, 2011, $1.9M — Catapult Ventures Group, Tate & Lyle Ventures
- Series A, Jun 11, 2009, $2.3M — Tate & Lyle Ventures, Scottish Enterprise

## Investors

- Tate & Lyle Ventures (https://capitalatlas.ai/funds/tate-lyle-ventures) — Series A, Series B
- Scottish Enterprise (https://capitalatlas.ai/funds/scottish-enterprise) — Series A, Series B
- Catapult Ventures Group (https://capitalatlas.ai/funds/catapult-ventures-group) — Series B